World Pharma Newsfeed
AstraZeneca updates on olaparib and TC-5214 development programmes
AstraZeneca announced that its investigational compound olaparib will not progress into Phase III development for the ma...
Four potential blockbusters in the Pharma pipeline
The Bayer Group plans to continue investing heavily in research and development and expects its Pharmaceuticals business...
Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars
Amgen (NASDAQ:AMGN) and Watson Pharmaceuticals, Inc. (NYSE:WPI) announced that they will collaborate to develop and comm...
Prevent Pneumococcal Disease in Infants and Young Children in the World's Poorest Countries
Pfizer Inc. (NYSE:PFE) has entered into a second supply agreement which will broaden and extend the duration of the Comp...
A gene that protects against colorectal cancers
The research team at Lyon has developed an animal model carrying a mutation of the DCC gene. Mice carrying the mutation ...
New light on medicinal benefits of plants
Scientists are about to make publicly available all the data they have so far on the genetic blueprint of medicinal plan...
Blood test might predict how well a depressed patient responds to antidepressants
Loyola University Medical Center researchers are reporting what could become the first reliable method to predict whethe...
Simcere and Bristol-Myers Squibb Enter Innovative Partnership
Bristol-Myers Squibb Company (NYSE: BMY) and Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company ...
GE Healthcare and M+W Group form strategic alliance in vaccines, insulin and biopharmaceuticals
GE Healthcare, the healthcare business of GE (NYSE: GE) and M+W Group, a leading global engineering, construction and pr...
IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
IBM (NYSE: IBM) announced it is contributing a massive database of chemical data extracted from millions of patents and ...
